Application of Antiosteoporosis Therapy in Osteolysis

Launched by HENAN CANCER HOSPITAL · Nov 14, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how a treatment for osteoporosis (a condition that weakens bones) can help patients who have had surgery for bone tumors in their arms or legs. Specifically, the trial will track any complications after surgery and how well the patients can use their limbs over the next 10 years. Researchers at Henan Cancer Hospital want to see if this osteoporosis therapy can improve recovery and limb function in these patients.

Anyone can join the study, regardless of age or gender, as long as they have been diagnosed with a type of bone tumor—whether it’s benign (non-cancerous), malignant (cancerous), or metastatic (cancer that has spread) and have had the tumor surgically removed at the hospital. Participants will be monitored for their recovery and any issues that arise after surgery. It’s important to note that the trial is not currently recruiting participants, but it will be an opportunity for those who qualify to contribute to important research that may help improve care for future patients facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. No age restriction, male or female.
• • 2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
• • 3. Received excision of bone tumor in research institution.
• Exclusion Criteria:
• • Not applicable.